Activators of Ran BP-3L function through various biochemical mechanisms to enhance its role in cellular processes. Compounds that upregulate adenylyl cyclase activity increase cAMP levels, which are known to regulate a myriad of cellular functions, including nucleocytoplasmic transport systems that often interact with Ran GTPases. Activation of protein kinase C similarly results in phosphorylation of key substrates that could influence the interactions of Ran BP-3L with its partner proteins, thereby modulating its activity. Calcium ionophores raise intracellular calcium concentrations, potentially impacting calcium-dependent signaling pathways and indirectly augmenting the function of Ran BP-3L in nuclear transport. Furthermore, the inhibition of protein phosphatases leads to a greater phosphorylation state within the cell, potentially enhancing Ran BP-3L activity by affecting the proteins that regulate the Ran GTPase cycle.
The use of proteasome inhibitors can lead to the stabilization of proteins within the nuclear transport machinery, thereby indirectly increasing the activity of Ran BP-3L by preventing the degradation of Ran GTPase-interacting proteins. Disrupting microtubule dynamics affects cell cycle progression and mitotic spindle formation, which may in turn influence the distribution and function of Ran-dependent transport, subsequently affecting Ran BP-3L's role in these processes. Inhibition of key kinases such as GSK-3 may alter the phosphorylation patterns of proteins involved in nuclear transport, potentially leading to an enhancement of Ran BP-3L function. Additionally, modulation of the soluble guanylate cyclase pathway alters cGMP levels, which could influence the Ran GTPase cycle and indirectly activate Ran BP-3L.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate proteins influencing the nuclear transport in which Ran BP-3L is involved. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Raises intracellular calcium levels, indirectly affecting the nucleocytoplasmic transport that Ran BP-3L regulates. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
A non-hydrolysable GTP analog, enhancing GTPase activities indirectly potentiating Ran BP-3L-mediated nuclear export. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibitor of protein phosphatases 1 and 2A, altering protein phosphorylation balance and indirectly influencing Ran BP-3L activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Modulates various signaling pathways, potentially influencing nuclear export processes where Ran BP-3L functions are crucial. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits tyrosine phosphatases, potentially enhancing phosphorylation-dependent processes involving Ran BP-3L. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, potentially influencing phosphorylation events that can indirectly activate Ran BP-3L. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter cellular trafficking pathways, indirectly affecting Ran BP-3L-dependent nuclear export. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, affecting the MAPK/ERK pathway, which can indirectly influence the nucleocytoplasmic shuttling mediated by Ran BP-3L. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK leading to alterations in cellular energy status, which could indirectly influence Ran BP-3L's role in nucleocytoplasmic transport. | ||||||